Carla Gallenga to Humans
This is a "connection" page, showing publications Carla Gallenga has written about Humans.
Connection Strength
0.045
-
How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy. J Biol Regul Homeost Agents. 2021 Jan-Feb; 35(1):379-383.
Score: 0.007
-
Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents. 2019 Jan-Feb,; 33(1):1-6.
Score: 0.006
-
Anaphylaxis is a rare reaction in COVID-19 vaccination. J Biol Regul Homeost Agents. 2021 May-Jun; 35(3):839-842.
Score: 0.002
-
Monoclonal antibody therapy in COVID-19. J Biol Regul Homeost Agents. 2021 Mar-Apr; 35(2):423-427.
Score: 0.002
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. J Biol Regul Homeost Agents. 2021 Jan-Feb; 35(1):1-4.
Score: 0.002
-
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. J Biol Regul Homeost Agents. 2020 Nov-Dec; 34(6):1971-1975.
Score: 0.002
-
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1623-1627.
Score: 0.002
-
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1629-1632.
Score: 0.002
-
SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines. J Biol Regul Homeost Agents. 2020 May-June,; 34(3):767-773.
Score: 0.002
-
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020 March-April,; 34(2):333-338.
Score: 0.002
-
Mesenchymal stem cells and IL-37: a powerful combination. J Biol Regul Homeost Agents. 2019 Jul-Aug; 33(4):1019-1022.
Score: 0.002
-
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? J Biol Regul Homeost Agents. 2019 May-Jun; 33(3):669-673.
Score: 0.002
-
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines. J Biol Regul Homeost Agents. 2019 Mar-Apr,; 33(2):315-319.
Score: 0.002
-
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines. Eur J Pharmacol. 2019 Feb 05; 844:87-94.
Score: 0.002
-
Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects. J Biol Regul Homeost Agents. 2018 Nov-Dec; 32(6):1355-1360.
Score: 0.002
-
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines. J Biol Regul Homeost Agents. 2018 Sep-Oct; 32(5):1061-1065.
Score: 0.002
-
Impact of mold on mast cell-cytokine immune response. J Biol Regul Homeost Agents. 2018 Jul-Aug; 32(4):763-768.
Score: 0.002
-
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators. J Biol Regul Homeost Agents. 2018 May-Jun; 32(3):449-454.
Score: 0.002
-
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. J Biol Regul Homeost Agents. 2018 Mar-Apr; 32(2):195-198.
Score: 0.002
-
Diagnosis of a neonatal ophthalmic discharge, Ophthalmia neonatorum, in the molecular age: investigation for a correct therapy. J Biol Regul Homeost Agents. 2018 Jan-Feb; 32(1):177-184.
Score: 0.001
-
The Role of Gene Therapy in the Treatment of Retinal Diseases: A Review. Curr Gene Ther. 2017; 17(3):194-213.
Score: 0.001